News & Updates

A study presented at EASD 2024 shows that microvascular complications of diabetes, such as diabetic neuropathy and retinopathy, are independently and concomitantly associated with moderate/severe periodontitis.

Among individuals with type 2 diabetes (T2D), those with higher serum 25-hydroxyvitamin D (25[OD]D) appear to have a lower risk of heart failure (HF), with the Mendelian randomization (MR) analysis pointing to a possible causal relationship.

The Netherlands Epidemiology of Obesity study presented at EASD 2024 shows a link between late chronotype and an increased risk of developing type 2 diabetes (T2D).

Osteoporosis screening with dual-energy X-ray absorptiometry (DXA) is recommended for all men ≥70 years of age and all women ≥65 years of age, according to 2024 guidelines of the Osteoporosis Society of Hong Kong (OSHK).

The combination of re-cellularization via electroporation therapy (ReCET) plus semaglutide appears to improve glucose control and metabolic health and eliminate the need for insulin therapy in most patients with type 2 diabetes (T2D), with the effects maintained up to 2 years, according to the follow-up data from the single-arm, dose-finding, first-in-human EMINENT trial.

The novel plant-based polyphenol-rich compound, TOTUM-63, helps keep the lid on fasting plasma glucose (FPG) and other measures of glucose dysregulation in people with prediabetes and early type 2 diabetes (T2D), according to the pivotal phase II/III REVERSE-IT study.